NorthCrest Asset Manangement’s Integra LifeSciences IART Stock Holding History

NorthCrest Asset Manangement’s Portfolio IART Stock Details IART Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-13,105	Closed	-$288K	–	643
2025 Q1	$288K	Buy	13,105 +5	+0%	+$118	0.01%	529
2024 Q4	$297K	Sell	13,100 -1,092	-8%	-$23.8K	0.01%	487
2024 Q3	$258K	Buy	14,192 +12	+0.1%	+$278	0.01%	508
2024 Q2	$413K	Hold	14,180	–	–	0.01%	406
2024 Q1	$503K	Sell	14,180 -200	-1%	-$8K	0.02%	385
2023 Q4	$626K	Hold	14,380	–	–	0.02%	337
2023 Q3	$549K	Sell	14,380 -300	-2%	-$12.6K	0.02%	347
2023 Q2	$604K	Hold	14,680	–	–	0.02%	327
2023 Q1	$843K	Buy	14,680 +500	+4%	+$28.2K	0.04%	285
2022 Q4	$795K	Buy	14,180 +380	+3%	+$19.3K	0.05%	215
2022 Q3	$585K	Hold	13,800	–	–	0.03%	280
2022 Q2	$746K	Hold	13,800	–	–	0.04%	251
2022 Q1	$887K	Buy	13,800 +200	+1%	+$13.2K	0.04%	219
2021 Q4	$911K	Buy	+13,600	New	+$920K	0.05%	237

Other funds holding IART

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

PCMI

Paradigm Capital Management Inc Albany, New York $2.61B AUM 78.58% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

NorthCrest Asset Manangement's IART Position: Q2 2025 in Review

NorthCrest Asset Manangement sold out of Integra LifeSciences (IART) in Q2 2025, closing a stake of 13,105 shares — an estimated $288K sold.

NorthCrest Asset Manangement first reported a position in IART in Q4 2021 and held it in 14 quarters. The position peaked at $911K in Q4 2021. 208 funds tracked by Wall St. Rank hold IART as of Q2 2025.

NorthCrest Asset Manangement reported no remaining Integra LifeSciences position as of Q2 2025 after selling out during the quarter.
NorthCrest Asset Manangement sold 13,105 Integra LifeSciences shares in Q2 2025, an estimated $288K.
NorthCrest Asset Manangement first reported a position in Integra LifeSciences in Q4 2021 and held it in 14 quarters.
NorthCrest Asset Manangement's Integra LifeSciences position peaked at $911K in Q4 2021.
208 funds tracked by Wall St. Rank held Integra LifeSciences as of Q2 2025.

Based on NorthCrest Asset Manangement's 13F filing for Q2 2025, filed 10 Jul 2025.